These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25492037)

  • 21. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.
    Briasoulis A; Inampudi C; Akintoye E; Alvarez P; Panaich S; Vaughan-Sarrazin M
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.
    Chung JE; Choi YR; Seong JM; La HO; Gwak HS
    Int J Clin Pharm; 2015 Dec; 37(6):1038-46. PubMed ID: 26068570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time in the therapeutic range during warfarin therapy in Japanese patients with non-valvular atrial fibrillation. - A multicenter study of its status and infuential factors-.
    Okumura K; Komatsu T; Yamashita T; Okuyama Y; Harada M; Konta Y; Hatayama T; Horiuchi D; Tsushima E
    Circ J; 2011; 75(9):2087-94. PubMed ID: 21737950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
    Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
    Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
    Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral anticoagulants usage in Japanese patients aged 18-74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims data.
    Ohshima A; Koyama T; Ogawa A; Zamami Y; Tanaka HY; Kitamura Y; Sendo T; Hinotsu S; Miller MW; Kano MR
    Fam Pract; 2019 Nov; 36(6):685-692. PubMed ID: 31329899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of uninterrupted low-intensity warfarin for cryoballoon ablation of atrial fibrillation in the elderly: A pilot study.
    Xing Y; Xu B; Sheng X; Xu C; Peng F; Sun Y; Wang S; Guo H
    J Clin Pharm Ther; 2018 Jun; 43(3):401-407. PubMed ID: 29484682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.
    Hayashi T; Kumagai K; Naito S; Goto K; Kaseno K; Ohshima S; Hachiya H; Hirao K; Isobe M
    Circ J; 2013; 77(2):338-44. PubMed ID: 23090638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation.
    Suzuki S; Yamashita T; Kato T; Fujino T; Sagara K; Sawada H; Aizawa T; Fu LT
    Circ J; 2007 May; 71(5):761-5. PubMed ID: 17457005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment.
    Pengo V; Barbero F; Biasiolo A; Pegoraro C; Noventa F; Iliceto S
    Thromb Haemost; 2003 Apr; 89(4):760-4. PubMed ID: 12669133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
    Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
    Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin anticoagulation intensity in Japanese nonvalvular atrial fibrillation patients: a J-RHYTHM Registry analysis.
    Yamashita T; Inoue H; Okumura K; Atarashi H; Origasa H;
    J Cardiol; 2015 Mar; 65(3):175-7. PubMed ID: 25169015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials) in Asian Patients With Atrial Fibrillation.
    Chan YH; Lee HF; Wang CL; Chang SH; Yeh CH; Chao TF; Yeh YH; Chen SA; Kuo CT
    J Am Heart Assoc; 2019 Nov; 8(21):e013053. PubMed ID: 31623498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of international normalized ratio to bleeding and thromboembolism rates in Taiwanese patients receiving vitamin K antagonist after mechanical valve replacement.
    Yu HY; Liu CH; Chen YS; Wang SS; Chu SH; Lin FY
    J Formos Med Assoc; 2005 Apr; 104(4):236-43. PubMed ID: 15909060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
    Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –.
    Hori M; Matsumoto M; Tanahashi N; Momomura S; Uchiyama S; Goto S; Izumi T; Koretsune Y; Kajikawa M; Kato M; Ueda H; Iwamoto K; Tajiri M;
    Circ J; 2012; 76(9):2104-11. PubMed ID: 22664783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.